| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| May 9, 2025 | Exagen Inc. Announces Closing of $20.2 Million Public Offering Including Full Exercise of Underwriter’s Option to Purchase Additional Shares | CARLSBAD, Calif., May 09, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced that it has completed the sale of an additional 502,500 shares of its common stock at a public... |
| Mar 31, 2025 | Liberty Announces Warrants to Commence Trading on March 31, 2025, Following Completion of $1.65 Unit Prospectus Offering with $2.05 Exercise Price Warrants to Trade under Symbol SCAN.WT | NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES.
VANCOUVER, British Columbia and WILMINGTON, Mass., March 31, 2025 (GLOBE NEWSWIRE) -- Liberty Defense Holdings Ltd. (“Liberty” or the “Company”) (TSXV: S... |
| Feb 7, 2025 | Nuvectis Pharma Announces Closing of $15.5 Million Public Offering of Common Stock and Full Exercise of Underwriter’s Over-Allotment Option | FORT LEE, NJ, Feb. 07, 2025 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (Nasdaq: NVCT), a clinical-stage biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious conditions of unmet m... |
| Jan 31, 2025 | Beta Bionics Announces Closing of $234.6 Million Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares | IRVINE, Calif., Jan. 31, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced the closing of its upsized initial public offering of 13,... |
| Jan 31, 2025 | Beta Bionics Announces Closing of $234.6 Million Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares | IRVINE, Calif., Jan. 31, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced the closing of its upsized initial public offering of 13,... |
| Nov 25, 2024 | Autonomix Medical, Inc. Announces Closing of $10.0 Million Underwritten Public Offering Including Partial Exercise of Over-Allotment Option | THE WOODLANDS, TX, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing precision nerve-targeted treatments, today announced the closing of it... |
| Nov 25, 2024 | Autonomix Medical, Inc. Announces Closing of $10.0 Million Underwritten Public Offering Including Partial Exercise of Over-Allotment Option | THE WOODLANDS, TX, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing precision nerve-targeted treatments, today announced the closing of it... |
| Nov 14, 2024 | Foremost Clean Energy Announces Closing of Brokered Private Placement for Gross Proceeds of C$10.5 Million Including Full Exercise of Over Allotment | NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES.
VANCOUVER, British Columbia, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Foremost Clean Energy Ltd. (NASDAQ: FMST) (CSE: FAT) (“Foremost” or the “Company”), an eme... |
| Sep 6, 2024 | Vaxcyte Announces Closing of $1.5 Billion Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares | SAN CARLOS, Calif., Sept. 06, 2024 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, announced ... |
| Aug 21, 2024 | Kymera Therapeutics Announces Closing of Upsized $225 Million Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares | WATERTOWN, Mass., Aug. 21, 2024 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of small molecule medicines using targeted protein degradation (TPD), today annou... |
| Aug 2, 2024 | Strategic Investors Exercise Warrants Early, Goliath Resources Receives Proceeds Of $1,822,814 | TORONTO, Aug. 02, 2024 (GLOBE NEWSWIRE) -- Goliath Resources Limited (TSX-V: GOT) (OTCQB: GOTRF) (FSE: B4IF) (the “Company” or “Goliath”) is pleased to report that based on positive drilling success early in the 2024 drill program has led t... |
| Aug 2, 2024 | Lundin Mining Announces Closing of $350 million Term Loan in Connection with the Caserones Option Exercise | Lundin Mining Announces Closing of $350 million Term Loan in Connection with the Caserones Option Exercise
Fri, Aug 02, 2024 23:30 CET Report this content
Vancouver, BC, August 2nd, 2024 /CNW/ - (TSX: LUN; Nasdaq Stockholm: LUMI) Lundin Min... |
| Aug 2, 2024 | Strategic Investors Exercise Warrants Early, Goliath Resources Receives Proceeds Of $1,822,814 | TORONTO, Aug. 02, 2024 (GLOBE NEWSWIRE) -- Goliath Resources Limited (TSX-V: GOT) (OTCQB: GOTRF) (FSE: B4IF) (the “Company” or “Goliath”) is pleased to report that based on positive drilling success early in the 2024 drill program has led t... |
| Jun 27, 2024 | Graf Global Corp. Announces Closing of $230 Million Initial Public Offering Including Full Exercise of Underwriters’ Over-Allotment Option | THE WOODLANDS, TX, June 27, 2024 (GLOBE NEWSWIRE) -- Graf Global Corp. (the “Company”) today announced the closing of its initial public offering of 23,000,000 units, which includes 3,000,000 units issued pursuant to the exercise by the und... |
| Jun 12, 2024 | Centurion Acquisition Corp. Announces Closing of $287.5 Million Initial Public Offering Including Full Exercise of Underwriters’ Over-Allotment Option | NEW YORK, June 12, 2024 (GLOBE NEWSWIRE) -- Centurion Acquisition Corp. (Nasdaq: ALF) (the “Company”) today announced the closing of its initial public offering of 28,750,000 units, which includes 3,750,000 units issued pursuant to the exer... |
| May 17, 2024 | Aqua Metals Announces Closing of $8.05 Million Public Offering of Common Stock, Including Full Exercise of Over-Allotment Option | |
| May 17, 2024 | Aqua Metals Announces Closing of $8.05 Million Public Offering of Common Stock, Including Full Exercise of Over-Allotment Option | RENO, Nev., May 17, 2024 (GLOBE NEWSWIRE) -- Aqua Metals, Inc. (Nasdaq: AQMS) (“Aqua Metals” or the “Company”), a pioneer in sustainable lithium-ion battery recycling, today announced the closing of its $8.05 million underwritten public off... |
| Apr 24, 2024 | Intra-Cellular Therapies Announces Closing of $575 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares | |
| Mar 28, 2024 | IB Acquisition Corp. Announces Closing of $115,000,000 Initial Public Offering, Including Full Exercise of Underwriter Over-Allotment Option | |
| Feb 14, 2024 | Kneat Announces Closing of $20 Million Bought Deal Including Full Exercise of Over-Allotment Option | |
| Feb 14, 2024 | Kneat Announces Closing of $20 Million Bought Deal Including Full Exercise of Over-Allotment Option | Not for distribution to United States newswire services or for dissemination in the United States
HALIFAX, Nova Scotia, Feb. 14, 2024 (GLOBE NEWSWIRE) -- kneat.com, inc. (TSX:KSI) (“Kneat” or the “Company”) announced today the closing of it... |
| Feb 2, 2024 | Corbus Pharmaceuticals Announces Closing of $94.5 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares | NORWOOD, Mass., Feb. 02, 2024 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (Nasdaq: CRBP) (“Corbus” or the “Company”), a precision oncology company with a diversified portfolio, today announced the closing of its public offerin... |
| Feb 2, 2024 | Vaxcyte Announces Closing of $862.5 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares | |
| Feb 2, 2024 | Vaxcyte Announces Closing of $862.5 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares | SAN CARLOS, Calif., Feb. 02, 2024 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, announced t... |
| Feb 2, 2024 | Corbus Pharmaceuticals Announces Closing of $94.5 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares | |
| Jan 29, 2024 | Tourmaline Bio Announces Closing of $172.5 Million Public Offering of Common Stock, Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares | |
| Jan 24, 2024 | JVSPAC Acquisition Corp. Announces Closing of $57.5 Million Initial Public Offering, Including Full Exercise of Underwriter's Over-Allotment Option | HONG KONG, Jan. 24, 2024 /PRNewswire/ -- JVSPAC Acquisition Corp. (NASDAQ:JVSAU) (the "Company"), a newly incorporated blank check company incorporated as a British Virgin Islands exempted company formed for the purpose of effecti... |
| Jan 9, 2024 | Kymera Therapeutics Announces Closing of Upsized $275 Million Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares | |
| Dec 22, 2023 | KULR Announces Closing of $1.035 Million All-Common Stock Public Offering, Including Full Exercise of Over-Allotment Option | |
| Dec 4, 2023 | Xenon Pharmaceuticals Announces Closing of $345.0 Million Upsized Public Offering Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares | |
| Aug 11, 2023 | LQR House Inc. Announces Closing of $5,750,000 Initial Public Offering, Including Exercise of Full Over-Allotment Option | |
| Jul 21, 2023 | Aqua Metals Announces Closing of $20 Million Public Offering of Common Stock, Including Full Exercise of Over-Allotment Option | /EIN News/ -- RENO, Nev., July 21, 2023 (GLOBE NEWSWIRE) -- Aqua Metals, Inc. (Nasdaq: AQMS) (“Aqua Metals” or the “Company”), a pioneer in sustainable lithium-ion battery recycling, today announced the closing of its $20 million underwritt... |
| Jul 21, 2023 | Aqua Metals Announces Closing of $20 Million Public Offering of Common Stock, Including Full Exercise of Over-Allotment Option | |
| Jul 12, 2023 | Osisko Metals Announces Closing of LIFE Financing of Flow-Through Shares for Gross Proceeds of $3.5 Million (Including Exercise in Full of Agents' Option) | |
| Jul 12, 2023 | Osisko Metals Announces Closing of LIFE Financing of Flow-Through Shares for Gross Proceeds of $3.5 Million (Including Exercise in Full of Agents' Option) | /EIN News/ -- NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
MONTREAL, July 12, 2023 (GLOBE NEWSWIRE) -- Osisko Metals Incorporated (the "Company" or "Osisko Metals") (TSX-V: OM;... |
| Jun 27, 2023 | Mullen Series D Holders Exercise Final $100 Million Investment Option Prior to June 30, 2023, Expiration | /EIN News/ -- Company is in its strongest financial position ever, with over $235 million in cash and cash equivalents, representing approximately 2 years of operating capital
BREA, Calif., June 27, 2023 (GLOBE NEWSWIRE) -- via IBN -- Mulle... |
| Jun 27, 2023 | Mullen Series D Holders Exercise Final $100 Million Investment Option Prior to June 30, 2023, Expiration | |
| Jun 22, 2023 | Dragonfly Energy Announces Closing of $20.0 Million Underwritten Public Offering and Partial Exercise of Over-Allotment Option | |
| May 23, 2023 | Aduro Clean Technologies Announces $1.49 Million in Proceeds from Exercise of Warrants | /EIN News/ -- SARNIA, Ontario, May 23, 2023 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. (“Aduro” or the “Company”) (CSE: ACT) (OTCQB: ACTHF) (FSE: 9D50), a Canadian technology company using the power of chemistry to transform lower va... |
| May 23, 2023 | Aduro Clean Technologies Announces $1.49 Million in Proceeds from Exercise of Warrants | |
| May 22, 2023 | Cabaletta Bio Announces Closing of $100 Million Public Offering of Common Stock, Including Full Exercise of Option to Purchase Additional Shares | |
| Apr 24, 2023 | Windtree Therapeutics Announces Closing of $12.42 Million Underwritten Public Offering Including Full Exercise of Overallotment Option | |
| Apr 21, 2023 | Vaxcyte Announces Closing of $575 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares | |
| Apr 21, 2023 | Vaxcyte Announces Closing of $575 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares | /EIN News/ -- SAN CARLOS, Calif., April 21, 2023 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseas... |
| Feb 28, 2023 | Mosaic Announces Proceeds of $400,000 From Warrants & Options Exercise | |
| Feb 17, 2023 | Mars Acquisition Corp. Announces Closing of $69 Million Initial Public Offering, Including Full Exercise of Underwriter's Over-Allotment Option | NEW YORK, Feb. 17, 2023 /PRNewswire/ -- Mars Acquisition Corp. (Nasdaq:MARXU) (the "Company"), a Cayman Islands exempted company incorporated as a blank check company for the purpose of effecting a merger, share exchange, asset ac... |
| Feb 14, 2023 | Pono Capital Three, Inc. Announces Closing of $115,000,000 Initial Public Offering and Full Exercise of Over-Allotment Option | |
| Dec 22, 2022 | Prime Mining Corp. Announces Closing of C$21.0M Million Bought Deal Private Placement Financing Including Full Exercise of Over-Allotment Option | |
| Dec 15, 2022 | Aduro Announces Receipt of Proceeds of Approximately $1.1 Million from Exercise of Warrants and Stock Options | |
| Dec 9, 2022 | ADMA Biologics Announces Closing of $69 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares | |
| Nov 17, 2022 | Daxor Corporation Announces Closing of $2.1 million Underwritten Public Offering and Exercise of Over-Allotment Option | |
| Oct 28, 2022 | Vaxcyte Announces Closing of $690 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares | SAN CARLOS, Calif., Oct. 28, 2022 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, announced t... |
| Sep 30, 2022 | Silo Pharma Announces Closing of $5.75 Million Public Offering of Common Stock, Nasdaq Listing, and Full Exercise of Underwriter’s Over-Allotment Option | ENGLEWOOD CLIFFS, NJ, Sept. 30, 2022 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, today announced the closing of... |
| Sep 29, 2022 | T2 Biosystems Announces BARDA Exercise of Contract Option 3 Valued at $3.7 Million | LEXINGTON, Mass., Sept. 29, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today that the Biomedical Advanced Research and D... |
| Aug 16, 2022 | Palisade Bio Announces Closing of $13.8 Million Upsized Underwritten Public Offering and Full Exercise of Over-Allotment Option | CARLSBAD, Calif., Aug. 16, 2022 (GLOBE NEWSWIRE) -- Palisade Bio (Nasdaq: PALI), a clinical stage biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (GI) complications, today announced the closing of its pr... |
| Aug 15, 2022 | Treasure Global Inc Announces Closing of Upsized $9.2 Million Initial Public Offering, Nasdaq Listing, and Full Exercise of Underwriter’s Over-Allotment Option | NEW YORK, Aug. 15, 2022 (GLOBE NEWSWIRE) -- Treasure Global Inc (Nasdaq: TGL) (“TGI”, or the “Company”), an innovative e-commerce platform providing seamless payment solutions and rewards programs, today announced the closing of its previou... |
| Aug 9, 2022 | SIGA Announces BARDA Exercise of Procurement Options Valued at Approximately $26 Million for IV TPOXX® | - IV TPOXX is an Important Option for Those Unable to Swallow –
- Option to Fund Post-Marketing Field Study for IV TPOXX also Exercised –
NEW YORK, Aug. 09, 2022 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercia... |
| Jun 29, 2022 | Else Nutrition Announces Closing of $7.35 Million Marketed Public Offering Of Units, Including Partial Exercise of Over-Allotment | NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.
VANCOUVER, British Columbia, June 29, 2022 (GLOBE NEWSWIRE) -- Else Nutrition Holdings Inc. (TSX: BABY) (the “Company” or “Else”), a leading... |
| Jun 27, 2022 | Xenon Pharmaceuticals Announces Closing of $287.5 Million Public Offering Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares | BURNABY, British Columbia, June 27, 2022 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical stage biopharmaceutical company, today announced the closing of its previously announced underwritten public offering of 9,098... |
| Jun 3, 2022 | Sachem Capital Corp. Announces Sale of an Additional $2.5 Million of 7.125% Notes from Exercise of Over Allotment Option | BRANFORD, Conn., June 03, 2022 (GLOBE NEWSWIRE) -- Sachem Capital Corp. (NYSE American: SACH) has sold an additional $2.5 million original principal amount of its 7.125% unsecured, unsubordinated notes due 2027 (“Notes”) pursuant to the exe... |
| May 3, 2022 | Chenghe Acquisition Co. Announces Closing of $115 Million Initial Public Offering and Exercise of Underwriters' Over-Allotment Option in Full | SINGAPORE, May 3, 2022 /PRNewswire/ -- Chenghe Acquisition Co. (Nasdaq: CHEAU) (the "Company") today announced the closing of its initial public offering of 11,500,000 units, which includes 1,500,000 units issued pursuant to the e... |
| Mar 31, 2022 | T2 Biosystems Announces BARDA Exercise of Contract Option 2B Valued at $4.4 Million | LEXINGTON, Mass., March 31, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today that the Biomedical Advanced Research and D... |
| Mar 15, 2022 | Nubia Brand International Corp. Announces Closing of Upsized $123,500,000 Initial Public Offering Including Partial Exercise of Over-Allotment Option | DALLAS, TX, March 15, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nubia Brand International Corp. (the "Company") today announced the closing of its upsized initial public offering of 12,350,000 units at $10.00 per unit, includin... |
| Mar 4, 2022 | H-CYTE Announces Proceeds of $1.05 Million from Warrant Exercise | TAMPA, Fla., March 04, 2022 (GLOBE NEWSWIRE) -- H-CYTE, Inc. (OTCQB: HCYT), a medical biosciences company, announced today that it has received $1,053,605 from the exercise of 75,257,511 previously issued warrants. The funds received will b... |
| Feb 17, 2022 | Splash Beverage Group Announces Closing of its Previously Announced $9.2 Million Underwritten Public Offering and Full Exercise of Underwriters’ Over-Allotment Option | Fort Lauderdale, Florida, Feb. 17, 2022 (GLOBE NEWSWIRE) -- Splash Beverage Group, Inc. (NYSE American: SBEV) (the “Company” or “Splash Beverage Group”), a portfolio company of leading beverage brands, today announced the closing of its pre... |
| Dec 10, 2021 | Adicet Bio, Inc. Announces Closing of $100 Million Public Follow-On Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares | |
| Oct 29, 2021 | LAVA Medtech Acquisition Corp. Announces Closing of $115 Million Initial Public Offering Including Full Exercise of the Over-Allotment Option | LAVA Medtech Acquisition Corp. (the “Company”) today announced the closing of its initial public offering of 11,500,000 units at a price of $10.00 per unit, including 1,500,000 units pursuant to the full exercise of the underwriters’ over-a... |
| Mar 12, 2021 | Xenon Pharmaceuticals Announces Closing of $115 Million Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares | |
| Dec 29, 2020 | Kubient Announces Closing of $20.7 Million Public Offering and Exercise of Overallotment Option | Kubient, Inc. , a cloud-based software platform for digital advertising, announced the closing of its previously announced underwritten public offering of 3,529,411 shares of its common stock at a price to the public of $5.10 per share. In ... |
| Jun 5, 2020 | Intellia Therapeutics Announces Closing of $115 Million Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares | |
| Dec 4, 2012 | Continental Gold Announces Closing of $86.3 Million Bought Deal Financing and Over-Allotment Option Exercise | TORONTO, ONTARIO (Marketwire – Dec. 4, 2012) |